|
Name |
(10E,12Z)-10,12-Octadecadienoic acid methyl ester
|
Molecular Formula | C19H34O2 | |
IUPAC Name* |
methyl (10E,12Z)-octadeca-10,12-dienoate
|
|
SMILES |
CCCCC/C=C\C=C\CCCCCCCCC(=O)OC
|
|
InChI |
InChI=1S/C19H34O2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19(20)21-2/h7-10H,3-6,11-18H2,1-2H3/b8-7-,10-9+
|
|
InChIKey |
KMXSXYSNZMSDFK-UQGDGPGGSA-N
|
|
Synonyms |
21870-97-3; methyl (10E,12Z)-octadeca-10,12-dienoate; (10E,12Z)-10,12-Octadecadienoic acid methyl ester; A64XK94MSS; T10,C12-cla methyl ester; Methyl linoleate, (10E,12Z)-; Methyl 10-trans-12-cis-linoleate; 10-trans-12-cis-octadecadienoic acid methyl ester; 10-trans,12-cis-Linoleic acid methyl ester; (10E,12Z)-MethylEster10,12-Octadecadienoate; 10-trans,12-cis-Octadecadienoic acid methyl ester; trans-10-cis-12-Octadecadienoic acid methyl ester; 10,12-Octadecadienoic acid, (10E,12Z)-, methyl ester; NSC707238; methyl 10-trans,12-cis-octadecadienoate; trans-10, methyl ester; UNII-A64XK94MSS; (10E,12Z)-Methyl linoleate; SCHEMBL5670193; CHEMBL2004275; DTXSID401021873; ZINC6010165; methyl-(e,z)-10,12-octadecadienoate; NSC-707238; METHYL-10tr,12c-OCTADECADIENOATE; trans-10,cis-12 Octadecadienoic acid methyl ester
|
|
CAS | 21870-97-3 | |
PubChem CID | 5471014 | |
ChEMBL ID | CHEMBL2004275 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 294.5 | ALogp: | 7.2 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 15 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 26.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 21 | QED Weighted: | 0.222 |
Caco-2 Permeability: | -4.586 | MDCK Permeability: | 0.00002330 |
Pgp-inhibitor: | 0.044 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.65 |
30% Bioavailability (F30%): | 0.985 |
Blood-Brain-Barrier Penetration (BBB): | 0.352 | Plasma Protein Binding (PPB): | 97.30% |
Volume Distribution (VD): | 1.066 | Fu: | 1.72% |
CYP1A2-inhibitor: | 0.901 | CYP1A2-substrate: | 0.351 |
CYP2C19-inhibitor: | 0.707 | CYP2C19-substrate: | 0.502 |
CYP2C9-inhibitor: | 0.439 | CYP2C9-substrate: | 0.941 |
CYP2D6-inhibitor: | 0.789 | CYP2D6-substrate: | 0.267 |
CYP3A4-inhibitor: | 0.931 | CYP3A4-substrate: | 0.145 |
Clearance (CL): | 5.968 | Half-life (T1/2): | 0.416 |
hERG Blockers: | 0.418 | Human Hepatotoxicity (H-HT): | 0.521 |
Drug-inuced Liver Injury (DILI): | 0.337 | AMES Toxicity: | 0.011 |
Rat Oral Acute Toxicity: | 0.034 | Maximum Recommended Daily Dose: | 0.518 |
Skin Sensitization: | 0.961 | Carcinogencity: | 0.112 |
Eye Corrosion: | 0.607 | Eye Irritation: | 0.878 |
Respiratory Toxicity: | 0.944 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001435 | 0.839 | D0O1PH | 0.537 | ||||
ENC001544 | 0.800 | D0O1TC | 0.519 | ||||
ENC001594 | 0.800 | D0OR6A | 0.469 | ||||
ENC001595 | 0.800 | D0UE9X | 0.444 | ||||
ENC001645 | 0.790 | D07ILQ | 0.395 | ||||
ENC001605 | 0.765 | D05ATI | 0.390 | ||||
ENC001657 | 0.765 | D09ANG | 0.381 | ||||
ENC000572 | 0.765 | D0H2YX | 0.375 | ||||
ENC001682 | 0.765 | D0Z5SM | 0.373 | ||||
ENC001680 | 0.765 | D0Z5BC | 0.371 |